Where does Ossur Iceland EHF rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ossur Iceland EHF ranks #2,131 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Ossur Iceland EHF hold?

Ossur Iceland EHF holds 185 US utility patents granted between 2016 and 2025, spanning 31 technology areas.

What is Ossur Iceland EHF's Innovation Score?

Ossur Iceland EHF has an Innovation Score of 54.5 out of 100 (top 8% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Ossur Iceland EHF's patent grant rate increasing or decreasing?

Ossur Iceland EHF's recent grant velocity is +172% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Ossur Iceland EHF's patents?

Ossur Iceland EHF's patents average 13.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Ossur Iceland EHF patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ossur Iceland EHF

Q: What technology areas does Ossur Iceland EHF focus on?

Ossur Iceland EHF's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 157 patents, ranking #35 of 3,082 assignees active in that subclass. Grants appear in 31 CPC subclasses total.

USPTO PatentsView assignee record - 185 granted patents across 31 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ossur ranks #2,131 of 49,997 tracked US assignees by granted-patent volume, with 185 patents across 31 technology areas.

#2,131
of 49,997 US assignees by volume: Top 8%
by Innovation Score (54.5/100): 13.9
avg claims per patent: +172%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2131 · Foreign Corporation #2,131 · 185 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 185 grants
TOP-DECILE #2,131/49,997
PHOTO-FINISH Canon Anelva
CPC-FOCUS A61F · 31 areas
INNOV-PAR 54.5/100
CLAIMS-RICH 13.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +172% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Canon Anelva Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ossur’s 54.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 18.1 pts (33%) Velocity 8.5 pts (16%) Breadth 19.7 pts (36%) Claim depth 8.3 pts (15%)

Qualcomm Incorporated · highest

85
Aisan Kogyo · near

55
Basf Mobile… · near

55
Chang Chun Petrochem… · near

55
Hesai Technology · near

55
Ossur Iceland EHF · this assignee

55
3D Lighting… · lowest

7

What this shows Ossur's Innovation Score is 54.5/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ossur?

Each dot is one of Ossur’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ossur’s own 13.9 claims/patent is ABOVE the 11.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ossur vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ossur's grants concentrate

Ossur Iceland EHF is a focused PatentsView assignee: 31 CPC subclasses with 84.9% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2022 (30 grants) versus a trough of 1 in 2016. By volume, Ossur sits between Canon Anelva Corporation and Raytheon BBN Technologies Corp..

Ossur's three-year grant acceleration

From 2019–2021 to 2022–2024, Ossur Iceland EHF moved from 67 to 85 grants (1.27x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #683. See the growth leaderboard.

Canon Anelva

185
Cooler Master

185
Fujitsu Semicondu…

185
National Taiwan U…

185
PETRÓLEO Brasilei…

185
Proterial

185
Perkinelmer Healt…

185
Raytheon BBN

185
Ossur Iceland EHF ◀

185

What this shows Ossur holds 185 patents at rank #2,131, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ossur

By rank, the assignees closest to #2,131 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Ossur's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ossur, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Ossur ranks #35 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (55 here).

Aisan Kogyo Kabushiki Kaisha 55 Chang Chun Petrochemical Co., Ltd. 55 Hesai Technology Co., Ltd. 55 Basf Mobile Emissions Catalysts, LLC 55

Similar claim depth

Nearest assignees by average claims per patent (13.9 here).

SUN Pharmaceutical Industries Limited 13.9 avg PlayNitride Inc. 13.9 avg MakerBot Industries, LLC 13.9 avg Ruprecht - Karls - UNIVERSITÄT Heidelberg 13.9 avg

Ossur's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

55 Top 8% higher than 92% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Ossur Iceland EHF patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	0.5%
2017	8	4.3%
2018	10	5.4%
2019	27	14.6%
2020	20	10.8%
2021	20	10.8%
2022	30	16.2%
2023	27	14.6%
2024	28	15.1%
2025partial year	14	7.6%

Which technologies does Ossur Iceland EHF patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 157

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 13

D04B - Knitting 9

A61B - DIAGNOSIS; SURGERY; Identification 7

F04B - Positive-displacement Machines FOR LIQUIDS; Pumps 7

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 6

F16C - SHAFTS; Flexible SHAFTS; Elements OR Crankshaft MECHANISMS; Rotary Bodies Other Than Gearing ELEMENTS; Bearings 5

D10B - Indexing Scheme Associated With Sublasses OF Section D, Relating TO Textiles 5

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 5

B25J - MANIPULATORS; Chambers Provided With Manipulation Devices 4

E05D - Hinges OR Suspension Devices FOR Doors, Windows OR Wings 4

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 4

A41D - OUTERWEAR; Protective GARMENTS; Accessories 4

A41F - Garment FASTENINGS; Suspenders 4

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 3

Top 15 of 31 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Ossur Iceland EHF's patent record in context - here's where to go next.

Ossur Iceland EHF's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 84.9% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #2,131 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ossur Iceland EHF against Canon Anelva Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 54.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.